Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Intracranial Activity of Gefitinib and Capmatinib in a Patient with Previously Treated Non-Small Cell Lung Cancer Harboring a Concurrent EGFR Mutation and MET Amplification.

Gainor JF, Stevens SE, Willers H, Shih HA, Heist RS.

J Thorac Oncol. 2020 Jan;15(1):e8-e10. doi: 10.1016/j.jtho.2019.07.024. No abstract available.

PMID:
31864558
2.

Proton therapy for head and neck paragangliomas: A single institutional experience.

Kang KH, Lebow ES, Niemierko A, Bussière MR, Dewyer NA, Daly J, McKenna MJ, Lee DJ, Loeffler JS, Busse PM, Shih HA.

Head Neck. 2019 Dec 18. doi: 10.1002/hed.26044. [Epub ahead of print]

PMID:
31850601
3.

The Interaction of Waiting Time and Patient Experience during Radiation Therapy: A Survey of Patients from a Tertiary Cancer Center.

Lamba N, Niemierko A, Martinez R, Leland P, Shih HA.

J Med Imaging Radiat Sci. 2019 Dec 12. pii: S1939-8654(19)30496-5. doi: 10.1016/j.jmir.2019.08.008. [Epub ahead of print]

PMID:
31839482
4.

Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.

McDuff SGR, Dietrich J, Atkins KM, Oh KS, Loeffler JS, Shih HA.

Cancer Med. 2020 Jan;9(1):3-11. doi: 10.1002/cam4.2686. Epub 2019 Nov 7. Review.

5.

Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis.

Lamba N, Hwang WL, Kim DW, Niemierko A, Marciscano AE, Mehan WA Jr, Benayoun MD, Curry WT, Barker FG 2nd, Martuza RL, Dunn IF, Claus E, Bi WL, Aizer AA, Alexander BM, Oh KS, Loeffler JS, Shih HA.

World Neurosurg. 2020 Jan;133:e804-e812. doi: 10.1016/j.wneu.2019.10.002. Epub 2019 Oct 9.

PMID:
31605839
6.

Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model.

Niyazi M, Niemierko A, Paganetti H, Söhn M, Schapira E, Goldberg S, Adams J, Kim V, Oh KS, Hwang WL, Lu HM, Belka C, Busse PM, Loeffler JS, Shih HA.

Radiother Oncol. 2019 Sep 25. pii: S0167-8140(19)33092-0. doi: 10.1016/j.radonc.2019.09.008. [Epub ahead of print]

PMID:
31563411
7.

Radiation Therapy Pain Management: Prevalence of Symptoms and Effectiveness of Treatment Options.

Lamba N, Mahal BA, Martinez R, Leland P, Shih HA.

Clin J Oncol Nurs. 2019 Oct 1;23(5):514-521. doi: 10.1188/19.CJON.514-521.

PMID:
31538974
8.

Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA).

Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu JB, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney NA, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP.

Clin Transl Radiat Oncol. 2019 Jun 27;18:39-45. doi: 10.1016/j.ctro.2019.06.007. eCollection 2019 Sep.

9.

Brachytherapy as an Adjuvant for Recurrent Atypical and Malignant Meningiomas.

Koch MJ, Agarwalla PK, Royce TJ, Shih HA, Oh K, Niemierko A, Mauceri TC, Curry WT, Barker FG, Loeffler JS.

Neurosurgery. 2019 Nov 1;85(5):E910-E916. doi: 10.1093/neuros/nyz115.

PMID:
31329941
10.

Assembling the brain trust: the multidisciplinary imperative in neuro-oncology.

Ludmir EB, Mahajan A, Ahern V, Ajithkumar T, Alapetite C, Bernier-Chastagner V, Bindra RS, Bishop AJ, Bolle S, Brown PD, Carrie C, Chalmers AJ, Chang EL, Chung C, Dieckmann K, Esiashvili N, Gandola L, Ghia AJ, Gondi V, Grosshans DR, Harrabi SB, Horan G, Indelicato DJ, Jalali R, Janssens GO, Krause M, Laack NN, Laperriere N, Laprie A, Li J, Marcus KJ, McGovern SL, Merchant TE, Merrell KW, Padovani L, Parkes J, Paulino AC, Schwarz R, Shih HA, Souhami L, Sulman EP, Taylor RE, Thorp N, Timmermann B, Wheeler G, Wolden SL, Woodhouse KD, Yeboa DN, Yock TI, Kortmann RD, McAleer MF.

Nat Rev Clin Oncol. 2019 Aug;16(8):521-522. doi: 10.1038/s41571-019-0235-z. No abstract available.

PMID:
31150024
11.

Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma.

Tabrizi S, Yeap BY, Sherman JC, Nachtigall LB, Colvin MK, Dworkin M, Fullerton BC, Daartz J, Royce TJ, Oh KS, Batchelor TT, Curry WT, Loeffler JS, Shih HA.

Radiother Oncol. 2019 Aug;137:95-101. doi: 10.1016/j.radonc.2019.04.027. Epub 2019 May 10.

PMID:
31082632
12.

Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?

Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu J, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney N, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP.

Transl Res. 2019 Jun;208:63-72. doi: 10.1016/j.trsl.2019.02.011. Epub 2019 Feb 27.

PMID:
30885538
13.

Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic Control.

Alvarez-Breckenridge C, Giobbie-Hurder A, Gill CM, Bertalan M, Stocking J, Kaplan A, Nayyar N, Lawrence DP, Flaherty KT, Shih HA, Oh K, Batchelor TT, Cahill DP, Sullivan R, Brastianos PK.

Oncologist. 2019 May;24(5):671-679. doi: 10.1634/theoncologist.2018-0306. Epub 2019 Feb 22.

14.

Patterns of Failure Among Patients With Low-grade Glioma Treated With Proton Radiation Therapy.

Kamran SC, Dworkin M, Niemierko A, Bussiere M, Oh KS, Loeffler JS, Shih HA.

Pract Radiat Oncol. 2019 Jul - Aug;9(4):e356-e361. doi: 10.1016/j.prro.2019.02.002. Epub 2019 Feb 18.

PMID:
30790717
15.

With Regard to the Brainstem, Size Matters Most.

Pike LRG, McKenna MJ, Shih HA.

Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):799-800. doi: 10.1016/j.ijrobp.2018.11.023. No abstract available.

PMID:
30784526
16.

Radiation tolerance of the optic pathway in patients treated with proton and photon radiotherapy.

Li PC, Liebsch NJ, Niemierko A, Giantsoudi D, Lessell S, Fullerton BC, Adams J, Shih HA.

Radiother Oncol. 2019 Feb;131:112-119. doi: 10.1016/j.radonc.2018.12.007. Epub 2018 Dec 31.

PMID:
30773177
17.

Hypopituitarism After Cranial Irradiation for Meningiomas: A Single-Institution Experience.

Lamba N, Bussiere MR, Niemierko A, Abedi P, Fullerton BC, Loeffler JS, Oh KS, Nachtigall LB, Shih HA.

Pract Radiat Oncol. 2019 May;9(3):e266-e273. doi: 10.1016/j.prro.2019.01.009. Epub 2019 Feb 4.

PMID:
30731274
18.

The association between blood urea nitrogen to creatinine ratio and mortality in patients with upper gastrointestinal bleeding.

Wu KH, Shih HA, Hung MS, Hsiao CT, Chen YC.

Arab J Gastroenterol. 2018 Dec;19(4):143-147. doi: 10.1016/j.ajg.2018.11.002. Epub 2018 Dec 3.

PMID:
30522883
19.

Long-term impact of a faculty mentoring program in academic medicine.

Efstathiou JA, Drumm MR, Paly JP, Lawton DM, O'Neill RM, Niemierko A, Leffert LR, Loeffler JS, Shih HA.

PLoS One. 2018 Nov 29;13(11):e0207634. doi: 10.1371/journal.pone.0207634. eCollection 2018.

20.

Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide.

Dworkin M, Mehan W, Niemierko A, Kamran SC, Lamba N, Dietrich J, Martinez-Lage M, Oh KS, Batchelor TT, Wen PY, Loeffler JS, Shih HA.

J Neurooncol. 2019 Mar;142(1):69-77. doi: 10.1007/s11060-018-03063-1. Epub 2018 Nov 28.

PMID:
30488294
21.

Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool.

Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Mehta MP.

Neuro Oncol. 2018 Nov 12;20(12):1652-1660. doi: 10.1093/neuonc/noy099.

22.

Enrichment of HER2 Amplification in Brain Metastases from Primary Gastrointestinal Malignancies.

Mitra D, Clark JW, Shih HA, Oh KS, Brastianos PK, Wo JY, Strickland MR, Curry WT, Parikh AR, Corcoran RB, Ryan DP, Iafrate AJ, Borger DR, Lennerz JK, Hong TS.

Oncologist. 2019 Feb;24(2):193-201. doi: 10.1634/theoncologist.2018-0152. Epub 2018 Oct 29.

23.

Subject-specific Brain Tumor Growth Modelling via An Efficient Bayesian Inference Framework.

Chang Y, Sharp GC, Li Q, Shih HA, El Fakhri G, Ra JB, Woo J.

Proc SPIE Int Soc Opt Eng. 2018 Feb;10574. pii: 105742I. doi: 10.1117/12.2293145. Epub 2018 Mar 2.

24.

Development and validation of NTCP models for acute side-effects resulting from proton beam therapy of brain tumours.

Dutz A, Lühr A, Agolli L, Troost EGC, Krause M, Baumann M, Vermeren X, Geismar D, Schapira EF, Bussière M, Daly JE, Bussière MR, Timmermann B, Shih HA, Löck S.

Radiother Oncol. 2019 Jan;130:164-171. doi: 10.1016/j.radonc.2018.06.036. Epub 2018 Jul 20.

PMID:
30033385
25.

Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases.

Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Mehta MP.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):845-853. doi: 10.1016/j.ijrobp.2018.04.006. Epub 2018 Apr 12.

26.

Proton Stereotactic Radiosurgery for Brain Metastases: A Single-Institution Analysis of 370 Patients.

Atkins KM, Pashtan IM, Bussière MR, Kang KH, Niemierko A, Daly JE, Botticello TM, Hurd MC, Chapman PH, Oh K, Loeffler JS, Shih HA.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):820-829. doi: 10.1016/j.ijrobp.2018.03.056. Epub 2018 Apr 4.

PMID:
29976494
27.

C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy.

Wang Y, Rapalino O, Heidari P, Loeffler J, Shih HA, Oh K, Mahmood U.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1024-1028. doi: 10.1016/j.ijrobp.2018.06.011. Epub 2018 Jun 18.

PMID:
29913253
28.

Immediate Radiation and Chemotherapy.

Kim DW, Shih HA.

Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):518. doi: 10.1016/j.ijrobp.2018.04.042. No abstract available.

PMID:
29893269
29.

Bacteremia in cirrhotic patients with upper gastrointestinal bleeding.

Shih HA, Tsai PC, Wu KH, Chen YT, Chen YC.

Turk J Gastroenterol. 2018 Mar;29(2):164-169. doi: 10.5152/tjg.2018.17309.

30.

The role of proton beam therapy in central neurocytoma: A single-institution experience.

Kang KH, Schapira E, Niemierko A, Martinez-Lage M, Bussière MR, Yock TI, Loeffler JS, Butler WE, Carter BS, Shih HA.

Pract Radiat Oncol. 2018 Sep - Oct;8(5):e305-e311. doi: 10.1016/j.prro.2018.02.005. Epub 2018 Feb 16.

PMID:
29706302
31.

Improved Overall Survival and Locoregional Disease Control With Concurrent PD-1 Pathway Inhibitors and Stereotactic Radiosurgery for Lung Cancer Patients With Brain Metastases.

Schapira E, Hubbeling H, Yeap BY, Mehan WA Jr, Shaw AT, Oh K, Gainor JF, Shih HA.

Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):624-629. doi: 10.1016/j.ijrobp.2018.02.175. Epub 2018 Mar 22.

PMID:
29678530
32.

Temozolomide therapy for aggressive functioning pituitary adenomas refractory to surgery and radiation: a case series.

Jordan JT, Miller JJ, Cushing T, Seijo M, Batchelor TT, Arrillaga-Romany IC, Shih HA, Nachtigall LB, Loeffler JS, Dietrich J.

Neurooncol Pract. 2018 Mar;5(1):64-68. doi: 10.1093/nop/npx013. Epub 2017 May 26.

33.

The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: intracranial progression, survival and toxicity.

Rahman R, Cortes A, Niemierko A, Oh KS, Flaherty KT, Lawrence DP, Sullivan RJ, Shih HA.

J Neurooncol. 2018 Jun;138(2):299-306. doi: 10.1007/s11060-018-2795-7. Epub 2018 Feb 16.

PMID:
29453679
34.

In Reply to McClelland et al.

Sanford NN, Shih HA.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):804. doi: 10.1016/j.ijrobp.2017.11.003. No abstract available.

PMID:
29413294
35.

Safety of Combined PD-1 Pathway Inhibition and Intracranial Radiation Therapy in Non-Small Cell Lung Cancer.

Hubbeling HG, Schapira EF, Horick NK, Goodwin KEH, Lin JJ, Oh KS, Shaw AT, Mehan WA, Shih HA, Gainor JF.

J Thorac Oncol. 2018 Apr;13(4):550-558. doi: 10.1016/j.jtho.2018.01.012. Epub 2018 Jan 31.

36.

Radiation Safety for Pregnant Workers at a Proton Facility.

Maquilan G, Bussière MR, McCormack J, Medich T, Niemierko A, Shih HA.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):560-564. doi: 10.1016/j.ijrobp.2017.11.016. Epub 2017 Nov 16.

PMID:
29306585
37.

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913.

Chinnaiyan P, Won M, Wen PY, Rojiani AM, Werner-Wasik M, Shih HA, Ashby LS, Michael Yu HH, Stieber VW, Malone SC, Fiveash JB, Mohile NA, Ahluwalia MS, Wendland MM, Stella PJ, Kee AY, Mehta MP.

Neuro Oncol. 2018 Apr 9;20(5):666-673. doi: 10.1093/neuonc/nox209.

38.

The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicity.

Jimenez RB, Alexander BM, Mahadevan A, Niemierko A, Rajakesari S, Arvold ND, Floyd SR, Oh KS, Loeffler JS, Shih HA.

Adv Radiat Oncol. 2017 Jun 6;2(3):391-397. doi: 10.1016/j.adro.2017.05.008. eCollection 2017 Jul-Sep.

39.

Estimating prognosis at the time of repeat whole brain radiation therapy for multiple brain metastases: The reirradiation score.

Logie N, Jimenez RB, Pulenzas N, Linden K, Ciafone D, Ghosh S, Xu Y, Lefresne S, Wong E, Son CH, Shih HA, Wong WW, Tyldesley S, Dennis K, Chow E, Fairchild AM.

Adv Radiat Oncol. 2017 Jun 14;2(3):381-390. doi: 10.1016/j.adro.2017.05.010. eCollection 2017 Jul-Sep.

40.

Multicriteria plan optimization in the hands of physicians: a pilot study in prostate cancer and brain tumors.

Müller BS, Shih HA, Efstathiou JA, Bortfeld T, Craft D.

Radiat Oncol. 2017 Nov 6;12(1):168. doi: 10.1186/s13014-017-0903-z.

41.

Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).

Sperduto PW, Jiang W, Brown PD, Braunstein S, Sneed P, Wattson DA, Shih HA, Bangdiwala A, Shanley R, Lockney NA, Beal K, Lou E, Amatruda T, Sperduto WA, Kirkpatrick JP, Yeh N, Gaspar LE, Molitoris JK, Masucci L, Roberge D, Yu J, Chiang V, Mehta M.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):812-816. doi: 10.1016/j.ijrobp.2017.06.2454.

42.

Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications.

Miller JJ, Shih HA, Andronesi OC, Cahill DP.

Cancer. 2017 Dec 1;123(23):4535-4546. doi: 10.1002/cncr.31039. Epub 2017 Oct 5. Review.

43.

Prospective, Randomized Study of Radiation Dose Escalation With Combined Proton-Photon Therapy for Benign Meningiomas.

Sanford NN, Yeap BY, Larvie M, Daartz J, Munzenrider JE, Liebsch NJ, Fullerton B, Pan E, Loeffler JS, Shih HA.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):787-796. doi: 10.1016/j.ijrobp.2017.07.008. Epub 2017 Jul 12.

44.

The role of radiotherapy in the management of high-grade meningiomas.

Hwang KL, Hwang WL, Bussière MR, Shih HA.

Chin Clin Oncol. 2017 Jul;6(Suppl 1):S5. doi: 10.21037/cco.2017.06.09. Review.

45.

Meningioma research-status quo and quo vadis.

Preusser M, Brastianos P, Shih HA.

Chin Clin Oncol. 2017 Jul;6(Suppl 1):S1. doi: 10.21037/cco.2017.06.21. No abstract available.

46.

The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases.

Sperduto PW, Jiang W, Brown PD, Braunstein S, Sneed P, Wattson DA, Shih HA, Bangdiwala A, Shanley R, Lockney NA, Beal K, Lou E, Amatruda T, Sperduto WA, Kirkpatrick JP, Yeh N, Gaspar LE, Molitoris JK, Masucci L, Roberge D, Yu J, Chiang V, Mehta M.

Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1069-1077. doi: 10.1016/j.ijrobp.2017.03.030. Epub 2017 Mar 29.

47.

Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas.

Kim D, Niemierko A, Hwang WL, Stemmer-Rachamimov AO, Curry WT, Barker FG, Martuza RL, Oh KS, Loeffler JS, Shih HA.

J Neurosurg. 2018 Apr;128(4):1123-1132. doi: 10.3171/2016.11.JNS16913. Epub 2017 Jun 16.

PMID:
28621619
48.

Analysis of patient outcomes following proton radiation therapy for retinoblastoma.

Mouw KW, Yeap BY, Caruso P, Fay A, Misra M, Sethi RV, MacDonald SM, Chen YL, Tarbell NJ, Yock TI, Freitag SK, Munzenrider JE, Grabowski E, Katz M, Kuhlthau K, DeCastro D, Heidary G, Ciralsky J, Mukai S, Shih HA.

Adv Radiat Oncol. 2017 Jan-Mar;2(1):44-52. doi: 10.1016/j.adro.2016.11.002.

49.

The role of image-guided intensity modulated proton therapy in glioma.

Grosshans DR, Mohan R, Gondi V, Shih HA, Mahajan A, Brown PD.

Neuro Oncol. 2017 Apr 1;19(suppl_2):ii30-ii37. doi: 10.1093/neuonc/nox002.

50.

Management of GBM: a problem of local recurrence.

Kirkpatrick JP, Laack NN, Shih HA, Gondi V.

J Neurooncol. 2017 Sep;134(3):487-493. doi: 10.1007/s11060-016-2347-y. Epub 2017 Apr 4. Review.

PMID:
28378194

Supplemental Content

Support Center